Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 28, 2019 08:15 ET | Source: Exagen, Inc.

Exagen Featured in Nine Scientific Presentations at 2019 ACR/ARHP Annual Meeting in Atlanta

SAN DIEGO, Oct. 28, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
October 24, 2019 08:20 ET | Source: Exagen, Inc.

AVISE® MTX Test from Exagen Supports Horizon Therapeutics plc Clinical Trial to Evaluate Pegloticase with Methotrexate to Enhance Response Rates for People Living with Uncontrolled Gout

SAN DIEGO, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), is pleased to announce clinical study support for Horizon Therapeutics plc (Nasdaq: HZNP) to measure methotrexate...
October 21, 2019 08:15 ET | Source: Exagen, Inc.

Exagen to Be Honored with National Research Innovation Award by Lupus Foundation of America

SAN DIEGO, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
October 15, 2019 08:15 ET | Source: Exagen, Inc.

Exagen Announces Publication of Two Key Studies Validating Clinical Performance of AVISE® Lupus in Patients with Probable SLE and Demonstrating Superior Clinical Utility Compared to Standard Diagnostic Testing

SAN DIEGO, Oct. 15, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune...
September 23, 2019 13:36 ET | Source: Exagen Inc.

Exagen Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

SAN DIEGO, Calif., Sept. 23, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
September 18, 2019 19:14 ET | Source: Exagen Inc.

Exagen Inc. Announces Pricing of Initial Public Offering

San Diego, CA, Sept. 18, 2019 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
August 19, 2019 08:57 ET | Source: Exagen Inc.

Exagen and the University of Washington Collaborate on Lupus and Rheumatoid Arthritis Research

San Diego, CA and Albuquerque, NM, Aug. 19, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
July 30, 2019 08:51 ET | Source: Exagen Inc.

Exagen Inc. Expands Board of Directors with its Appointment of Chet Burrell, Tina Nova and Bruce Robertson

San Diego, CA and Albuquerque, NM, July 30, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
July 16, 2019 08:49 ET | Source: Exagen Inc.

Exagen Inc. Completes $22.6 Million Financing

San Diego, CA and Albuquerque, NM, July 16, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., an organization dedicated to transforming the care continuum for patients suffering from debilitating and chronic...
April 24, 2019 09:55 ET | Source: Exagen Diagnostics, Inc.

New Biomarker Available to Offer Insight into Thrombosis for Lupus Sufferers

San Diego, CA and Albuquerque, NM, April 24, 2019 (GLOBE NEWSWIRE) -- Exagen Inc., a leader in helping rheumatologist and their patients in the diagnosis, prognosis, and management of chronic...